These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6455320)

  • 1. The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age.
    Riley WJ; McConnell TJ; Maclaren NK; McLaughlin JV; Taylor G
    Diabetes; 1981 Sep; 30(9):718-23. PubMed ID: 6455320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.
    Rossini AA; Appel MC; Williams RM; Like AA
    Diabetes; 1977 Oct; 26(10):916-20. PubMed ID: 143386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
    Sandler S; Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings.
    Cossel L; Schneider E; Kuttler B; Schmidt S; Wohlrab F; Schade J; Bochmann C
    Exp Clin Endocrinol; 1985 Feb; 85(1):7-26. PubMed ID: 3157595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
    Sandler S; Andersson A
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged refractoriness to the diabetogenic action of streptozotocin in mice.
    Abramovici Y; Agarwal MK
    Biochem Med; 1985 Dec; 34(3):259-66. PubMed ID: 2937403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice.
    Karabatas LM; Pastorale C; de Bruno LF; Maschi F; Pivetta OH; Lombardo YB; Chemes H; Basabe JC
    Pancreas; 2005 May; 30(4):318-24. PubMed ID: 15841040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
    Leiter EH; Beamer WG; Shultz LD
    Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin enhances diabetes induced by low-dose streptozotocin treatment in mice.
    Sestier C; Odent-Pogu S; Bonneville M; Maurel C; Lang F; Sai P
    Immunol Lett; 1985; 10(1):57-60. PubMed ID: 3159656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury.
    Eizirik DL; Pipeleers DG; Ling Z; Welsh N; Hellerström C; Andersson A
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9253-6. PubMed ID: 7937750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice.
    Maruyama T; Takei I; Yanagawa T; Takahashi T; Asaba Y; Kataoka K; Ishii T
    Diabetes Res; 1988 Feb; 7(2):93-6. PubMed ID: 3293880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin.
    Bonnevie-Nielsen V; Steffes MW; Lernmark A
    Diabetes; 1981 May; 30(5):424-9. PubMed ID: 6453032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair synthesis in the pancreatic islets of streptozotocin-treated mice.
    Sandler S; Swenne I
    Diabetes Res; 1985 Sep; 2(5):255-8. PubMed ID: 2933209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of (-)15-deoxyspergualin on pancreatic islet B-cell function in vitro and on the development of diabetes after multiple low dose streptozotocin administration.
    Strandell E; Andersson A; Groth CG; Sandler S
    Pharmacol Toxicol; 1989 Aug; 65(2):114-8. PubMed ID: 2530505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characteristics of cultured mouse pancreatic islets following exposure to different streptozotocin concentrations.
    Strandell E; Eizirik DL; Korsgren O; Sandler S
    Mol Cell Endocrinol; 1988 Sep; 59(1-2):83-91. PubMed ID: 2974003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.
    Leiter EH
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
    Pour PM; Kazakoff K; Carlson K
    Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice.
    Linn T; Loewk E; Schneider K; Federlin K
    Diabetologia; 1993 Dec; 36(12):1245-51. PubMed ID: 8307251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic-histochemical characterization of inflammatory cells in insulitis induced by multiple subdiabetogenic doses of streptozotocin in C57B1/KsJ mice.
    Schneider E; Wohlrab F; Cossel L
    Biomed Biochim Acta; 1984; 43(5):683-90. PubMed ID: 6236802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.